Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Hair Repigmentation: A Marker of Anti-PD-1 Treatment Response?

Tuesday, July 18, 2017
The approval of new targeted agents has expanded treatment options for patients with cancer. However, because they are so new, their side effect profile and associated adverse events have not been fully elucidated.

Clinicians in Spain noted a new adverse event—hair repigmentation—secondary to anti–programmed cell death 1 (anti–PD-1) and anti–programmed cell death ligand 1 (anti–PD-L1) therapy for non–small cell lung cancer and published their observations in JAMA Dermatology.

The July 12, 2017 report described 14 patients who developed hair repigmentation after anti–PD-1/anti–PD-L1 treatment, which consisted of a diffuse darkening of the hair in 13 of the 14 patients and the development of black patches between white hairs in one patient. Thirteen of the 14 patients had a good clinical response to treatment, with at least stable disease, and one had to discontinue treatment after 4 cycles because of progressive disease.

The authors concluded that this is the first published report of hair repigmentation secondary to anti–PD-1/anti–PD-L1 therapy for lung cancer and may be a response marker for these patients. The study findings are available here.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.